DALLAS, March 1, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions through its Phytiva brand product line is very pleased that Florida has taken this action toward providing safe access to medical marijuana for its people, as the country unites behind legalization on a step by step, state by state basis. The Florida bill, "The Cathy Jordan Medical Cannabis Act," introduced on Wednesday, is named after a Florida woman with Lou Gehrig's disease who found cannabis to be her preferred treatment for severe pain. Seventy percent of Floridians support access to medical marijuana.
The medical marijuana industry continues to evolve and grow, expanding people's opportunities across the country to access critical cannabinoid-based ailment formulations made possible by the medically significant cannabinoids found in the cannabis plant. This incremental legalization of medical marijuana in the U.S. seems to be accelerating with new vigor. More states are now joining in than ever before, recognizing the value of medical marijuana for patients who need safe and legal access for treatment of their ailments.
"This is clearly a positive development for medical patients. It is also a tremendous opportunity for X-Change Corp., as the Company prepares its strategy for entering an ever-expanding market for its Phytiva brand in providing formulations to help patients across the country. The Company intends to enter all available markets, both domestically and internationally, with its Phytiva brand product lines," stated Chad Johnson, General Counsel & COO of X-Change Corp.
Florida is the most recent state in which legislators have submitted a bill to pass a medical marijuana law. Other states considering cannabis-related measures include Alabama, Arkansas, Hawaii, Iowa, Kentucky, Idaho, Maine, Maryland, Michigan, New Hampshire, Nevada, North Carolina, Oklahoma, Rhode Island, and West Virginia. The Company is monitoring developments in these important states, while it continues to focus its strategic planning and alliances in all states and jurisdictions where the Company can currently operate and conduct business with full legal authority in providing its formulations to medical patients.
About The X-Change Corporation
X-Change Corp. is U.S. Company specializing in Cannabinoid based extracts and products that target medical cannabis, nutraceutical, cosmeceutical, and social usage solutions through multiple Phytiva Brand product lines, products, and services. These new Phytiva lines will be launched with cannabinoid based formulations through the launching of a combination of retail and wholesale products, medical cannabis dispensaries, cannabis research in clinics and laboratories, as announced for example with the Maliseet Nation in Canada, and other legal state and foreign grow operations, on a jurisdiction by jurisdiction approved basis.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
SOURCE X-Change Corporation